Scientific Interchange & Workshop


Exploring Recent Updates in the Treatment of Veno-Occlusive Disease in Adults and Pediatrics

October 24th 2024

Advancing Multiple Myeloma Care: From Frontline Strategies to Novel Therapies in Relapsed/Refractory Settings​

October 22nd 2024

Advancements in CLL Treatment: Optimizing Outcomes with Novel Therapeutics and Strategies​

October 9th 2024

OncLive NSCLC Early Career Clinical Trial Review: ASCO 2024

October 9th 2024

Standardizing Molecular Biomarker Testing for Lung Cancer Patients Across the Northwell Health System​

September 9th 2024

Best Practices for Advancing Treatments in Newly Diagnosed and Relapsed/Refractory MM

August 29th 2024

The Evolving Treatment Landscape of Multiple Myeloma: Translating Evidence to Clinical Practice

August 28th 2024

Precision Medicine in Breast Cancer: Targeted Therapies and Biomarker-Guided Treatment Strategies

July 17th 2024

The Rapidly Evolving Treatment Landscape of Stage I-IIIB NSCLC and its Implications to Clinical Practice

July 11th 2024

Emerging Treatment Strategies for Non-Melanoma Skin Cancer

June 28th 2024

Advances in the Long-Term Management of Acute Myeloid Leukemia

June 24th 2024

An Evolving Treatment Paradigm: ADCs in Non-Small Cell Lung Cancer

April 5th 2024

Exploring the Evolving Treatment Landscape and Therapeutic Challenges in Polycythemia Vera

January 11th 2024

This article was sponsored by PharmaEssentia.

Current and Emerging Therapeutic Advances in Follicular Lymphoma

October 23rd 2023

Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia: Where are we in 2023?

July 19th 2023

Therapeutic Considerations Across the Disease Continuum of HER2+ Breast Cancer

June 9th 2023

Bridging Current Practices and New Therapeutic Developments in Breast Cancer

June 8th 2023

Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice

April 19th 2023

Clinical Decision Making in Advanced NSCLC without Actionable Mutations

March 16th 2023

BTK Inhibitors in MCL and CLL

March 10th 2023